You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Cardinal Health announces quarterly dividend
13 February 2023 -

Cardinal Health (NYSE: CAH), a US-based distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities, on Friday announced its quarterly dividend.

The company has declared dividend of USD0.4957 per share out of its capital surplus.

The dividend will be paid to shareholders of record at 3 April 2023 on 15 April 2023.

Login
Username:

Password:


Related Headlines

Halozyme Therapeutics reports Q1 2023 financial results

Puma Biotechnology Posts 1Q23 Results

Pfizer declares results for first-quarter 2023

Eli Lilly and Company announces Q2 2023 dividend

Report Looks at Global Neurology Clinical Trials Market

Boehringer Ingelheim reports strong 2022 performance

Navamedic ASA announces cash offer to acquire all Sensidose AB shares

Navamedic announces cash offer to acquire Sensidose for approximately SEK75m

European Commission Grants Orphan Designation for iECURE's Lead Product Candidate GTP-506 for the Treatment of Ornithine Transcarbamylase Deficiency

Xeris Biopharma achieves fourth quarter net product revenue of USD32.5m

Amgen announces Q2 2023 dividend

West Pharmaceutical Services declares Q2 2022 dividend

Nordic Nanovector ASA reports full year results for 2022

Devyser Diagnostics AB announces full year 2022 results

Abbott announces quarterly common dividend

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2023